Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in HumansGreetje J. de Grooth, John J.P. Kastelein, Jan Albert Kuivenhoven et al.|Circulation|2002Cited by 455
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL SubclassesDimitri P. Mikhailidis, Evangelos Liberopoulos, Bruce A. Griffin et al.|Current Vascular Pharmacology|2011Cited by 197
The Inflammasome and Caspase-1 Activation: A New Mechanism Underlying Increased Inflammatory Activity in Human Visceral Adipose TissueTim B. Koenen, Jacqueline de Graaf|Endocrinology|2011Cited by 111